Tumor-derived extracellular vesicles activate primary monocytes. 2018

Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
Research Unit Gene Vectors, Helmholtz Center Munich German Research Center for Environmental Health, Munich, Germany.

Tumor cells educate immune effector cells in their vicinity by releasing factors that manipulate their phenotype and function. In fact, the thus generated immunosuppressive tumor microenvironment constitutes an integral part and a hallmark of solid tumors and contributes significantly to tumor development and immune escape. It has long been thought that soluble factors like prostaglandin E2 and TGF-β are the main mediators of these effects. But tumor cells also constantly release large number of extracellular vesicles (EVs), which are important conveyors of immune responses. We show here that tumor-derived EVs interact with primary monocytes and induce an activated phenotype, which is also observed in tumor-associated macrophages. Thus, both tumor-derived EVs and soluble factors together collaborate to form the immunosuppressive milieu of the tumor environment.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067128 Extracellular Vesicles Membrane limited structures derived from cell membranes and cytoplasmic material, and released into EXTRACELLULAR SPACE. They circulate through the EXTRACELLULAR FLUID and through the peripheral blood in the MICROVASCULATURE where cells, much larger, cannot, thereby affecting a variety of intercellular communication processes. Apoptotic Bodies,Exovesicles,Apoptotic Body,Bodies, Apoptotic,Body, Apoptotic,Exovesicle,Extracellular Vesicle,Vesicle, Extracellular,Vesicles, Extracellular
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments
D019139 Tumor Escape The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity (IMMUNITY, CELLULAR) and humoral immunity (ANTIBODY FORMATION), and also costimulatory pathways related to CD28 ANTIGENS and B7-1 ANTIGEN. Immune Escape, Tumor,Immune Evasion, Tumor,Tumor Immune Evasion,Evasion, Tumor Immune,Evasions, Tumor Immune,Immune Evasions, Tumor,Tumor Immune Escape,Tumor Immune Evasions

Related Publications

Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
January 2018, Frontiers in immunology,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
December 2021, Cells,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
June 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
January 2017, Frontiers in oncology,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
January 2020, PloS one,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
January 2023, Expert review of molecular diagnostics,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
August 2020, International journal of molecular sciences,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
January 2022, Life sciences,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
February 2021, Cells,
Kathrin Gärtner, and Christina Battke, and Judith Dünzkofer, and Corinna Hüls, and Bettina von Neubeck, and Mar-Kus Kellner, and Elena Fiestas, and Susanne Fackler, and Stephan Lang, and Reinhard Zeidler
April 2024, Cells,
Copied contents to your clipboard!